A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Clinical trial NCT01844674 · COMPLETED
Trial details
- NCT number
- NCT01844674
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-02
- Primary completion
- 2014-08-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.